Unknown

Dataset Information

0

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders.


ABSTRACT: Children with many inherited nonmalignant disorders can be cured or their condition alleviated by hematopoietic stem cell transplantation (HSCT). Umbilical cord blood (UCB) units are a rapidly available stem cell source and offer great flexibility in HLA matching, allowing nearly uniform access to HSCT. Although reduced-intensity conditioning (RIC) regimens promise decreased treatment-related morbidity and mortality, graft failure and infections have limited their use in chemotherapy-naive patients. We prospectively evaluated a novel RIC regimen of alemtuzumab, hydroxyurea, fludarabine, melphalan, and thiotepa with a single-unit UCB graft in 44 consecutive patients with inborn errors of metabolism, immunity, or hematopoiesis. In addition, 5% of the UCB graft was re-cryopreserved and reserved for cord donor leukocyte infusion (cDLI) posttransplant. All patients engrafted at a median of 15 days posttransplant, and chimerism was >90% donor in the majority of patients at 1-year posttransplant with only 1 secondary graft failure. The incidence of grade II to IV graft-versus-host disease (GVHD) was 27% (95% confidence interval [CI], 17-43) with no extensive chronic GVHD. Overall survival was 95% (95% CI, 83-99) and 85% (95% CI, 64-93) at 1 and 5 years posttransplant, respectively. No significant end-organ toxicities were observed. The use of cDLI did not affect GVHD and showed signals of efficacy for infection control or donor chimerism. This RIC transplant regimen using single-unit UCB graft resulted in outstanding survival and remarkably low rates of graft failure. Implementation of the protocol not requiring pharmacokinetic monitoring would be feasible and applicable worldwide for children with inherited disorders of metabolism, immunity, or hematopoiesis. This trial was registered at www.clinicaltrials.gov as #NCT01962415.

SUBMITTER: Vander Lugt MT 

PROVIDER: S-EPMC7362374 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3947864 | biostudies-literature
| S-EPMC4867292 | biostudies-literature
| S-EPMC6373757 | biostudies-literature
| S-EPMC4403859 | biostudies-literature
| S-EPMC10165184 | biostudies-literature
| S-EPMC2897972 | biostudies-literature
| S-EPMC8366386 | biostudies-literature
| S-EPMC3262108 | biostudies-literature
| S-EPMC4737113 | biostudies-other
| S-EPMC3419979 | biostudies-other